Inventor · disambiguated record
Nazzareno Dimasi
Also filed as: DIMASI NAZZARENO
12 granted patents·19 pending applications·60 citations·filing 2008–2025
87Inventor score
Top patents by PatentIndex Score
31 records- 0195US9527927B2Modified polypeptides for bispecific antibody scaffoldsMEDIMMUNE LLC·Filed 2012·Granted Dec 27, 2016·41 cites·11 claims
- 0290US11203633B2Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas pervMEDIMMUNE LTD·Filed 2020·Granted Dec 21, 2021·2 cites·25 claims
- 0389US9580509B2Multispecific and multivalent binding proteins and uses thereofMEDIMMUNE LLC·Filed 2012·Granted Feb 28, 2017·9 cites·18 claims
- 0484US10160812B2Bispecific HER2 antibodiesMEDIMMUNE LLC·Filed 2015·Granted Dec 25, 2018·4 cites·18 claims
- 0581US10597439B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LLC·Filed 2012·Granted Mar 24, 2020·4 cites·7 claims
- 0677US12428473B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LTD·Filed 2021·Granted Sep 30, 2025·0 cites·20 claims
- 0772US2025243262A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LTD·Filed 2025·Application pending·0 cites
- 0867US11634483B2Nucleic acids encoding anti-VEGF-A antibodies and uses thereofMEDIMMUNE LTD·Filed 2021·Granted Apr 25, 2023·0 cites·4 claims
- 0966US11566068B2Nucleic acids encoding bispecific anti-VEGF and anti-ANG2 antibodies and uses thereofMEDIMMUNE LTD·Filed 2020·Granted Jan 31, 2023·0 cites·4 claims
- 1062US2022160882A1Method of conjugating a polypeptideMEDIMMUNE LLC·Filed 2021·Application pending·0 cites
- 1162US2009155275A1Multispecific epitope binding proteins and uses thereofMEDIMMUNE LLC·Filed 2008·Application pending·0 cites
- 1261US10836819B2Anti-VEGF-A and anti-ANG2 antibodies and uses thereofMEDIMMUNE LTD·Filed 2017·Granted Nov 17, 2020·0 cites·7 claims
- 1359US2011033378A1Cysteine Engineered Antibodies For Site-Specific ConjugationMEDIMMUNE LLC·Filed 2009·Application pending·0 cites
- 1458US10919958B2Anti-VEGF-A antibodies and uses thereofMEDIMMUNE LTD·Filed 2017·Granted Feb 16, 2021·0 cites·5 claims
- 1556US2013295098A1Multispecific epitope binding proteins and uses thereofMEDIMMUNE LLC·Filed 2013·Application pending·0 cites
- 1654US2024123081A1Branched moiety for use in conjugatesMEDIMMUNE LLC·Filed 2019·Application pending·0 cites
- 1753US2013330350A1Antibody Scaffold For Homogenous ConjugationDIMASI NAZZARENO·Filed 2011·Application pending·0 cites
- 1853US2023279092A1Immunocytokines for treatment of autoimmune and inflammatory conditionsVIELA BIO INC·Filed 2021·Application pending·0 cites
- 1949US2017183408A1Antibody scaffold for homogenous conjugationMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 2049US2020289660A1Pyrrolobenzodiazepine conjugatesMEDIMMUNE LTD·Filed 2018·Application pending·0 cites
- 2148US2017114151A1Multispecific and multivalent binding proteins and uses thereofMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 2248US2010233173A1Multispecific epitope binding proteins and uses thereofMEDIMMUNE LLC·Filed 2010·Application pending·0 cites
- 2346US11649250B2Pyrrolobenzodiazepine conjugatesMEDIMMUNE LTD·Filed 2018·Granted May 16, 2023·0 cites·31 claims
- 2446US2017183414A1Cysteine engineered antibodies for site-specific conjugationMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 2545US2015284450A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LLC·Filed 2013·Application pending·0 cites
- 2643US11414477B2Methods for preparing antibodies with a defined glycosylation patternMEDIMMUNE LLC·Filed 2017·Granted Aug 16, 2022·0 cites·13 claims
- 2743US2014155581A1Methods For Making Multimeric PolypeptidesMEDIMMUNE LLC·Filed 2012·Application pending·0 cites
- 2843US2012213705A1ENGINEERED Fc REGIONS FOR SITE-SPECIFIC CONJUGATIONDIMASI NAZZARENO·Filed 2010·Application pending·0 cites
- 2942US2016017023A1Engineered Fc Regions For Site-Specific ConjugationMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 3039US2017304460A1Method of conjugating a polypeptideMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 3136US2017183397A1Multi-specific anti-pseudomonas psl and pcrv binding molecules and uses thereofMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →